

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | melanin metabolic process (GO:0006582) | 9.78455653 |
| 2 | secondary metabolite biosynthetic process (GO:0044550) | 8.99892094 |
| 3 | developmental pigmentation (GO:0048066) | 5.47237925 |
| 4 | neuronal action potential propagation (GO:0019227) | 4.53530635 |
| 5 | signal peptide processing (GO:0006465) | 4.29135486 |
| 6 | regulation of somitogenesis (GO:0014807) | 4.27769109 |
| 7 | phenol-containing compound biosynthetic process (GO:0046189) | 4.01920222 |
| 8 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 4.00671013 |
| 9 | presynaptic membrane assembly (GO:0097105) | 3.97294050 |
| 10 | neuron cell-cell adhesion (GO:0007158) | 3.76659265 |
| 11 | postsynaptic membrane organization (GO:0001941) | 3.72443269 |
| 12 | indolalkylamine metabolic process (GO:0006586) | 3.72122344 |
| 13 | indole-containing compound catabolic process (GO:0042436) | 3.70186556 |
| 14 | indolalkylamine catabolic process (GO:0046218) | 3.70186556 |
| 15 | tryptophan catabolic process (GO:0006569) | 3.70186556 |
| 16 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.65169139 |
| 17 | myelination in peripheral nervous system (GO:0022011) | 3.64656262 |
| 18 | peripheral nervous system axon ensheathment (GO:0032292) | 3.64656262 |
| 19 | regulation of timing of cell differentiation (GO:0048505) | 3.62753121 |
| 20 | presynaptic membrane organization (GO:0097090) | 3.58127447 |
| 21 | dermatan sulfate biosynthetic process (GO:0030208) | 3.53942980 |
| 22 | dermatan sulfate metabolic process (GO:0030205) | 3.51478354 |
| 23 | photoreceptor cell maintenance (GO:0045494) | 3.47267621 |
| 24 | kynurenine metabolic process (GO:0070189) | 3.45185175 |
| 25 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.43161623 |
| 26 | behavioral response to nicotine (GO:0035095) | 3.41750882 |
| 27 | secondary metabolic process (GO:0019748) | 3.35035532 |
| 28 | locomotory exploration behavior (GO:0035641) | 3.32218881 |
| 29 | tachykinin receptor signaling pathway (GO:0007217) | 3.30763095 |
| 30 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.23122382 |
| 31 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.22089816 |
| 32 | inner ear receptor cell differentiation (GO:0060113) | 3.20907684 |
| 33 | melanocyte differentiation (GO:0030318) | 3.18475469 |
| 34 | mechanoreceptor differentiation (GO:0042490) | 3.16616461 |
| 35 | neural tube formation (GO:0001841) | 3.15959296 |
| 36 | regulation of platelet aggregation (GO:0090330) | 3.13761284 |
| 37 | central nervous system neuron axonogenesis (GO:0021955) | 3.12169468 |
| 38 | detection of light stimulus involved in visual perception (GO:0050908) | 3.11850063 |
| 39 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.11850063 |
| 40 | reflex (GO:0060004) | 3.10860258 |
| 41 | establishment of protein localization to Golgi (GO:0072600) | 3.09601506 |
| 42 | regulation of sarcomere organization (GO:0060297) | 3.07840312 |
| 43 | somatic stem cell division (GO:0048103) | 3.07308382 |
| 44 | gamma-aminobutyric acid transport (GO:0015812) | 3.05843670 |
| 45 | regulation of development, heterochronic (GO:0040034) | 3.04247666 |
| 46 | chondroitin sulfate catabolic process (GO:0030207) | 3.01946657 |
| 47 | glycosphingolipid biosynthetic process (GO:0006688) | 2.99351684 |
| 48 | auditory receptor cell differentiation (GO:0042491) | 2.98875201 |
| 49 | regulation of hippo signaling (GO:0035330) | 2.95579807 |
| 50 | tryptophan metabolic process (GO:0006568) | 2.95167368 |
| 51 | serotonin metabolic process (GO:0042428) | 2.94250927 |
| 52 | behavioral response to ethanol (GO:0048149) | 2.91740825 |
| 53 | pigment cell differentiation (GO:0050931) | 2.89525601 |
| 54 | positive regulation of developmental pigmentation (GO:0048087) | 2.88212322 |
| 55 | indole-containing compound metabolic process (GO:0042430) | 2.87879799 |
| 56 | myelin assembly (GO:0032288) | 2.87620342 |
| 57 | cilium morphogenesis (GO:0060271) | 2.87526377 |
| 58 | cell differentiation involved in metanephros development (GO:0072202) | 2.86679481 |
| 59 | chondroitin sulfate biosynthetic process (GO:0030206) | 2.86102820 |
| 60 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.84332022 |
| 61 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.80534525 |
| 62 | C4-dicarboxylate transport (GO:0015740) | 2.80183558 |
| 63 | positive regulation of neuroblast proliferation (GO:0002052) | 2.80079700 |
| 64 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.79413296 |
| 65 | otic vesicle formation (GO:0030916) | 2.79135380 |
| 66 | cellular response to sterol (GO:0036315) | 2.77776571 |
| 67 | regulation of pigment cell differentiation (GO:0050932) | 2.77503727 |
| 68 | nonmotile primary cilium assembly (GO:0035058) | 2.76824232 |
| 69 | fucose catabolic process (GO:0019317) | 2.75955774 |
| 70 | L-fucose metabolic process (GO:0042354) | 2.75955774 |
| 71 | L-fucose catabolic process (GO:0042355) | 2.75955774 |
| 72 | transmission of nerve impulse (GO:0019226) | 2.75216414 |
| 73 | cell-cell junction maintenance (GO:0045217) | 2.74943654 |
| 74 | appendage development (GO:0048736) | 2.74564402 |
| 75 | limb development (GO:0060173) | 2.74564402 |
| 76 | proline transport (GO:0015824) | 2.73503939 |
| 77 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.72985782 |
| 78 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.72274211 |
| 79 | cranial nerve structural organization (GO:0021604) | 2.71874265 |
| 80 | righting reflex (GO:0060013) | 2.71510402 |
| 81 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.70704671 |
| 82 | protein localization to synapse (GO:0035418) | 2.69763196 |
| 83 | positive regulation of synapse assembly (GO:0051965) | 2.68638436 |
| 84 | axoneme assembly (GO:0035082) | 2.65959626 |
| 85 | cellular ketone body metabolic process (GO:0046950) | 2.63829781 |
| 86 | retinal cone cell development (GO:0046549) | 2.63229457 |
| 87 | axon ensheathment (GO:0008366) | 2.62944973 |
| 88 | ensheathment of neurons (GO:0007272) | 2.62944973 |
| 89 | benzene-containing compound metabolic process (GO:0042537) | 2.62525654 |
| 90 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.61938488 |
| 91 | pigmentation (GO:0043473) | 2.61491365 |
| 92 | ketone body metabolic process (GO:1902224) | 2.61424694 |
| 93 | primary amino compound metabolic process (GO:1901160) | 2.59889332 |
| 94 | amine catabolic process (GO:0009310) | 2.59743591 |
| 95 | cellular biogenic amine catabolic process (GO:0042402) | 2.59743591 |
| 96 | neuroepithelial cell differentiation (GO:0060563) | 2.59699241 |
| 97 | limb bud formation (GO:0060174) | 2.59127125 |
| 98 | oligodendrocyte differentiation (GO:0048709) | 2.58330787 |
| 99 | synaptic transmission, glutamatergic (GO:0035249) | 2.57574256 |
| 100 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.57016576 |
| 101 | negative regulation of mast cell activation (GO:0033004) | 2.56981774 |
| 102 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.55248454 |
| 103 | inner ear receptor stereocilium organization (GO:0060122) | 2.53296593 |
| 104 | cilium organization (GO:0044782) | 2.52267205 |
| 105 | platelet dense granule organization (GO:0060155) | 2.52014678 |
| 106 | prenylation (GO:0097354) | 2.51176226 |
| 107 | protein prenylation (GO:0018342) | 2.51176226 |
| 108 | protein K11-linked deubiquitination (GO:0035871) | 2.49624205 |
| 109 | cilium assembly (GO:0042384) | 2.48868177 |
| 110 | spinal cord association neuron differentiation (GO:0021527) | 2.47899301 |
| 111 | nucleobase catabolic process (GO:0046113) | 2.47869708 |
| 112 | negative regulation of platelet activation (GO:0010544) | 2.45234898 |
| 113 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.44973021 |
| 114 | myelination (GO:0042552) | 2.44603856 |
| 115 | urinary tract smooth muscle contraction (GO:0014848) | 2.44534687 |
| 116 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.44333654 |
| 117 | regulation of neuroblast proliferation (GO:1902692) | 2.44243244 |
| 118 | membrane depolarization during action potential (GO:0086010) | 2.43213452 |
| 119 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.42838943 |
| 120 | endocardial cushion morphogenesis (GO:0003203) | 2.42826549 |
| 121 | phasic smooth muscle contraction (GO:0014821) | 2.42809212 |
| 122 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.42770877 |
| 123 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.42770877 |
| 124 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.42770877 |
| 125 | startle response (GO:0001964) | 2.42344270 |
| 126 | male sex determination (GO:0030238) | 2.41854845 |
| 127 | protein localization to cilium (GO:0061512) | 2.41759471 |
| 128 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.41479018 |
| 129 | vocalization behavior (GO:0071625) | 2.41194680 |
| 130 | cell differentiation in spinal cord (GO:0021515) | 2.41183469 |
| 131 | central nervous system myelination (GO:0022010) | 2.40631960 |
| 132 | axon ensheathment in central nervous system (GO:0032291) | 2.40631960 |
| 133 | thyroid hormone metabolic process (GO:0042403) | 2.39594609 |
| 134 | positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568) | 2.39514480 |
| 135 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.39482439 |
| 136 | long-term synaptic potentiation (GO:0060291) | 2.39455554 |
| 137 | protein polyglutamylation (GO:0018095) | 2.39099674 |
| 138 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.39001528 |
| 139 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.38810983 |
| 140 | regulation of gene silencing by miRNA (GO:0060964) | 2.38810983 |
| 141 | regulation of gene silencing by RNA (GO:0060966) | 2.38810983 |
| 142 | response to pheromone (GO:0019236) | 2.38454436 |
| 143 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.37955890 |
| 144 | sulfation (GO:0051923) | 2.37478101 |
| 145 | fibroblast migration (GO:0010761) | 2.37376993 |
| 146 | mesenchyme morphogenesis (GO:0072132) | 2.37312921 |
| 147 | Leydig cell differentiation (GO:0033327) | 2.37041546 |
| 148 | sphingoid metabolic process (GO:0046519) | 2.36769557 |
| 149 | DNA double-strand break processing (GO:0000729) | 2.36495770 |
| 150 | tyrosine metabolic process (GO:0006570) | 2.36391763 |
| 151 | DNA methylation involved in gamete generation (GO:0043046) | 2.35971896 |
| 152 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.35868535 |
| 153 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.35868535 |
| 154 | nephron tubule development (GO:0072080) | 2.35470379 |
| 155 | spinal cord motor neuron differentiation (GO:0021522) | 2.33150506 |
| 156 | enteric nervous system development (GO:0048484) | 2.33086548 |
| 157 | astrocyte development (GO:0014002) | 2.30494102 |
| 158 | ganglion development (GO:0061548) | 2.29955074 |
| 159 | generation of neurons (GO:0048699) | 2.28319228 |
| 160 | neuronal action potential (GO:0019228) | 2.27982156 |
| 161 | peripheral nervous system development (GO:0007422) | 2.27818542 |
| 162 | regulation of homotypic cell-cell adhesion (GO:0034110) | 2.27522061 |
| 163 | relaxation of smooth muscle (GO:0044557) | 2.27125622 |
| 164 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.26588456 |
| 165 | auditory receptor cell stereocilium organization (GO:0060088) | 2.26465601 |
| 166 | glial cell migration (GO:0008347) | 2.26370783 |
| 167 | glutamate receptor signaling pathway (GO:0007215) | 2.25055522 |
| 168 | renal tubule development (GO:0061326) | 2.24398526 |
| 169 | regulation of male gonad development (GO:2000018) | 2.23575173 |
| 170 | exploration behavior (GO:0035640) | 2.22488665 |
| 171 | regulation of synapse assembly (GO:0051963) | 2.22089640 |
| 172 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 2.21793541 |
| 173 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.20781206 |
| 174 | neuronal ion channel clustering (GO:0045161) | 2.20681195 |
| 175 | neuron-neuron synaptic transmission (GO:0007270) | 2.20626751 |
| 176 | behavioral response to pain (GO:0048266) | 2.20040325 |
| 177 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.18976916 |
| 178 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.18232758 |
| 179 | melanin biosynthetic process (GO:0042438) | 10.7535690 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.07147623 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.25736779 |
| 3 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.85289028 |
| 4 | VDR_22108803_ChIP-Seq_LS180_Human | 2.76256832 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.65271182 |
| 6 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.61782006 |
| 7 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.46123430 |
| 8 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.42673218 |
| 9 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.40673557 |
| 10 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.37898785 |
| 11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.32006261 |
| 12 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.26737734 |
| 13 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.21953394 |
| 14 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.21953394 |
| 15 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.18992753 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.12690666 |
| 17 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.10487751 |
| 18 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.09622142 |
| 19 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.09214783 |
| 20 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 2.07697165 |
| 21 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.02270310 |
| 22 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.97806568 |
| 23 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.95726669 |
| 24 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.92800566 |
| 25 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.92582949 |
| 26 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.88697053 |
| 27 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.87910847 |
| 28 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.87827939 |
| 29 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.83233525 |
| 30 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.82103246 |
| 31 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.81969862 |
| 32 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.81079344 |
| 33 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.80568394 |
| 34 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.79999102 |
| 35 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.72735241 |
| 36 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.72317871 |
| 37 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.70400369 |
| 38 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.70063252 |
| 39 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.66914640 |
| 40 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.66559163 |
| 41 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.64859549 |
| 42 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.63849307 |
| 43 | P300_19829295_ChIP-Seq_ESCs_Human | 1.60766360 |
| 44 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.56336429 |
| 45 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.54909497 |
| 46 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.54909497 |
| 47 | TP53_16413492_ChIP-PET_HCT116_Human | 1.52163906 |
| 48 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.48845372 |
| 49 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.48489927 |
| 50 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.48442718 |
| 51 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.47356399 |
| 52 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.45148511 |
| 53 | FUS_26573619_Chip-Seq_HEK293_Human | 1.43764922 |
| 54 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.41871378 |
| 55 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.39688810 |
| 56 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.37078644 |
| 57 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.35814184 |
| 58 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.35807622 |
| 59 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.35772830 |
| 60 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.34974013 |
| 61 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.34974013 |
| 62 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.34213134 |
| 63 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.34170328 |
| 64 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.31176391 |
| 65 | * TCF4_22108803_ChIP-Seq_LS180_Human | 1.30525996 |
| 66 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.30200665 |
| 67 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.29524786 |
| 68 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.29332552 |
| 69 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.29122077 |
| 70 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.27883805 |
| 71 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.27819252 |
| 72 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.26095459 |
| 73 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.25914155 |
| 74 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.25838055 |
| 75 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.24893427 |
| 76 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.23482146 |
| 77 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.23341941 |
| 78 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.22767882 |
| 79 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.22767882 |
| 80 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.21925166 |
| 81 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.21922840 |
| 82 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.21561028 |
| 83 | TCF4_23295773_ChIP-Seq_U87_Human | 1.21347962 |
| 84 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.21327008 |
| 85 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21155453 |
| 86 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.20948983 |
| 87 | AR_25329375_ChIP-Seq_VCAP_Human | 1.20821866 |
| 88 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.20236725 |
| 89 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.19646224 |
| 90 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.19490525 |
| 91 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.17645309 |
| 92 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.17250400 |
| 93 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.17191535 |
| 94 | CJUN_26792858_Chip-Seq_BT549_Human | 1.15904460 |
| 95 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.15892085 |
| 96 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.15632686 |
| 97 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.14942632 |
| 98 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.12778312 |
| 99 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.11930881 |
| 100 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.10871176 |
| 101 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.09001971 |
| 102 | RXR_22108803_ChIP-Seq_LS180_Human | 1.08707334 |
| 103 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.08517480 |
| 104 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.07922377 |
| 105 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.07250941 |
| 106 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.07226493 |
| 107 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.06792143 |
| 108 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.06792143 |
| 109 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.06343437 |
| 110 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.05358725 |
| 111 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.04908834 |
| 112 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.04703975 |
| 113 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.04375119 |
| 114 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.04256342 |
| 115 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.03934426 |
| 116 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.03410388 |
| 117 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.03380761 |
| 118 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.02812854 |
| 119 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02469218 |
| 120 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.02169838 |
| 121 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02162422 |
| 122 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.01400961 |
| 123 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.01141002 |
| 124 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.00660992 |
| 125 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.00634963 |
| 126 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.99596131 |
| 127 | EWS_26573619_Chip-Seq_HEK293_Human | 0.99394631 |
| 128 | KDM2B_26808549_Chip-Seq_REH_Human | 0.98993524 |
| 129 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.98685626 |
| 130 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.96914248 |
| 131 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.96379418 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005171_absent_coat_pigmentation | 7.04617242 |
| 2 | MP0000372_irregular_coat_pigmentation | 5.60492666 |
| 3 | MP0003136_yellow_coat_color | 5.46904229 |
| 4 | MP0004381_abnormal_hair_follicle | 2.90310399 |
| 5 | MP0005377_hearing/vestibular/ear_phenot | 2.78676438 |
| 6 | MP0003878_abnormal_ear_physiology | 2.78676438 |
| 7 | MP0003195_calcinosis | 2.54894554 |
| 8 | MP0002102_abnormal_ear_morphology | 2.46257866 |
| 9 | MP0001501_abnormal_sleep_pattern | 2.41867458 |
| 10 | MP0005408_hypopigmentation | 2.39647264 |
| 11 | MP0005551_abnormal_eye_electrophysiolog | 2.33332179 |
| 12 | MP0005257_abnormal_intraocular_pressure | 2.25960215 |
| 13 | MP0002095_abnormal_skin_pigmentation | 2.25868935 |
| 14 | MP0003941_abnormal_skin_development | 2.17684530 |
| 15 | MP0002877_abnormal_melanocyte_morpholog | 2.16466526 |
| 16 | MP0010386_abnormal_urinary_bladder | 2.03919514 |
| 17 | MP0000015_abnormal_ear_pigmentation | 2.02731546 |
| 18 | MP0001968_abnormal_touch/_nociception | 2.02027629 |
| 19 | MP0002938_white_spotting | 2.01899341 |
| 20 | MP0006276_abnormal_autonomic_nervous | 1.86475404 |
| 21 | MP0004043_abnormal_pH_regulation | 1.76750091 |
| 22 | MP0001188_hyperpigmentation | 1.75475270 |
| 23 | MP0003646_muscle_fatigue | 1.74442789 |
| 24 | MP0000427_abnormal_hair_cycle | 1.70148940 |
| 25 | MP0000371_diluted_coat_color | 1.69701090 |
| 26 | MP0008438_abnormal_cutaneous_collagen | 1.66842184 |
| 27 | MP0002075_abnormal_coat/hair_pigmentati | 1.65654148 |
| 28 | MP0000920_abnormal_myelination | 1.61720855 |
| 29 | MP0005409_darkened_coat_color | 1.60769163 |
| 30 | MP0001485_abnormal_pinna_reflex | 1.59530037 |
| 31 | MP0005075_abnormal_melanosome_morpholog | 1.57236626 |
| 32 | MP0006292_abnormal_olfactory_placode | 1.55204964 |
| 33 | MP0002736_abnormal_nociception_after | 1.54472926 |
| 34 | MP0001186_pigmentation_phenotype | 1.52000259 |
| 35 | MP0005646_abnormal_pituitary_gland | 1.51632498 |
| 36 | MP0004134_abnormal_chest_morphology | 1.51614223 |
| 37 | MP0004859_abnormal_synaptic_plasticity | 1.48223152 |
| 38 | MP0002272_abnormal_nervous_system | 1.43730570 |
| 39 | MP0000383_abnormal_hair_follicle | 1.43148768 |
| 40 | MP0004742_abnormal_vestibular_system | 1.41235859 |
| 41 | MP0001970_abnormal_pain_threshold | 1.38858525 |
| 42 | MP0005503_abnormal_tendon_morphology | 1.38473219 |
| 43 | MP0003879_abnormal_hair_cell | 1.37849180 |
| 44 | MP0004858_abnormal_nervous_system | 1.37116515 |
| 45 | MP0006072_abnormal_retinal_apoptosis | 1.36590582 |
| 46 | MP0001963_abnormal_hearing_physiology | 1.35492308 |
| 47 | MP0002067_abnormal_sensory_capabilities | 1.35319995 |
| 48 | MP0001324_abnormal_eye_pigmentation | 1.34505693 |
| 49 | MP0004885_abnormal_endolymph | 1.34402698 |
| 50 | MP0003950_abnormal_plasma_membrane | 1.30172319 |
| 51 | MP0005174_abnormal_tail_pigmentation | 1.29380367 |
| 52 | MP0003880_abnormal_central_pattern | 1.29063508 |
| 53 | MP0000026_abnormal_inner_ear | 1.26282741 |
| 54 | MP0004924_abnormal_behavior | 1.25883489 |
| 55 | MP0005386_behavior/neurological_phenoty | 1.25883489 |
| 56 | MP0004147_increased_porphyrin_level | 1.22454702 |
| 57 | MP0002837_dystrophic_cardiac_calcinosis | 1.21886306 |
| 58 | MP0009250_abnormal_appendicular_skeleto | 1.21466305 |
| 59 | MP0004272_abnormal_basement_membrane | 1.19896856 |
| 60 | MP0000778_abnormal_nervous_system | 1.19408775 |
| 61 | MP0000538_abnormal_urinary_bladder | 1.19339595 |
| 62 | MP0005623_abnormal_meninges_morphology | 1.18958672 |
| 63 | MP0005248_abnormal_Harderian_gland | 1.18557467 |
| 64 | MP0005645_abnormal_hypothalamus_physiol | 1.18378432 |
| 65 | MP0002638_abnormal_pupillary_reflex | 1.15281010 |
| 66 | MP0000569_abnormal_digit_pigmentation | 1.14567939 |
| 67 | MP0002876_abnormal_thyroid_physiology | 1.13914755 |
| 68 | MP0006054_spinal_hemorrhage | 1.13354105 |
| 69 | MP0000534_abnormal_ureter_morphology | 1.12390593 |
| 70 | MP0003787_abnormal_imprinting | 1.12313048 |
| 71 | MP0002184_abnormal_innervation | 1.10176123 |
| 72 | MP0008057_abnormal_DNA_replication | 1.09717294 |
| 73 | MP0009046_muscle_twitch | 1.09624174 |
| 74 | MP0002735_abnormal_chemical_nociception | 1.06566149 |
| 75 | MP0000631_abnormal_neuroendocrine_gland | 1.05819824 |
| 76 | MP0003635_abnormal_synaptic_transmissio | 1.04572677 |
| 77 | MP0002557_abnormal_social/conspecific_i | 1.03746110 |
| 78 | MP0003634_abnormal_glial_cell | 1.03727869 |
| 79 | MP0000566_synostosis | 1.02479937 |
| 80 | MP0002734_abnormal_mechanical_nocicepti | 0.97439217 |
| 81 | MP0003633_abnormal_nervous_system | 0.95964528 |
| 82 | MP0002928_abnormal_bile_duct | 0.94366587 |
| 83 | MP0010678_abnormal_skin_adnexa | 0.93130279 |
| 84 | MP0003385_abnormal_body_wall | 0.92897146 |
| 85 | MP0002229_neurodegeneration | 0.92592279 |
| 86 | MP0003937_abnormal_limbs/digits/tail_de | 0.92273719 |
| 87 | MP0008872_abnormal_physiological_respon | 0.91964271 |
| 88 | MP0005379_endocrine/exocrine_gland_phen | 0.91789875 |
| 89 | MP0001486_abnormal_startle_reflex | 0.91772886 |
| 90 | MP0008569_lethality_at_weaning | 0.91187223 |
| 91 | MP0005195_abnormal_posterior_eye | 0.90762167 |
| 92 | MP0001958_emphysema | 0.90546612 |
| 93 | MP0002751_abnormal_autonomic_nervous | 0.89422501 |
| 94 | MP0001299_abnormal_eye_distance/ | 0.88837821 |
| 95 | MP0002909_abnormal_adrenal_gland | 0.88668321 |
| 96 | MP0000049_abnormal_middle_ear | 0.88550164 |
| 97 | MP0005670_abnormal_white_adipose | 0.87920957 |
| 98 | MP0002168_other_aberrant_phenotype | 0.87703290 |
| 99 | MP0004142_abnormal_muscle_tone | 0.87688407 |
| 100 | MP0004145_abnormal_muscle_electrophysio | 0.87626584 |
| 101 | MP0003890_abnormal_embryonic-extraembry | 0.86860579 |
| 102 | MP0002009_preneoplasia | 0.86573231 |
| 103 | MP0001984_abnormal_olfaction | 0.86306042 |
| 104 | MP0002089_abnormal_postnatal_growth/wei | 0.85987920 |
| 105 | MP0002090_abnormal_vision | 0.85355545 |
| 106 | MP0003942_abnormal_urinary_system | 0.83481283 |
| 107 | MP0002064_seizures | 0.83221280 |
| 108 | MP0009745_abnormal_behavioral_response | 0.81974297 |
| 109 | MP0003045_fibrosis | 0.80793951 |
| 110 | MP0002177_abnormal_outer_ear | 0.80384952 |
| 111 | MP0000647_abnormal_sebaceous_gland | 0.80096621 |
| 112 | MP0005253_abnormal_eye_physiology | 0.79766342 |
| 113 | MP0004085_abnormal_heartbeat | 0.79554642 |
| 114 | MP0002653_abnormal_ependyma_morphology | 0.79163397 |
| 115 | MP0005197_abnormal_uvea_morphology | 0.76828779 |
| 116 | MP0005423_abnormal_somatic_nervous | 0.76826329 |
| 117 | MP0002249_abnormal_larynx_morphology | 0.74869669 |
| 118 | MP0001905_abnormal_dopamine_level | 0.74249819 |
| 119 | MP0002752_abnormal_somatic_nervous | 0.73999947 |
| 120 | MP0000762_abnormal_tongue_morphology | 0.73218930 |
| 121 | MP0001529_abnormal_vocalization | 0.73089080 |
| 122 | MP0002063_abnormal_learning/memory/cond | 0.72869951 |
| 123 | MP0002572_abnormal_emotion/affect_behav | 0.72604112 |
| 124 | MP0002109_abnormal_limb_morphology | 0.72438131 |
| 125 | MP0001664_abnormal_digestion | 0.72414347 |
| 126 | MP0002882_abnormal_neuron_morphology | 0.72335346 |
| 127 | MP0000516_abnormal_urinary_system | 0.72124623 |
| 128 | MP0005367_renal/urinary_system_phenotyp | 0.72124623 |
| 129 | MP0002733_abnormal_thermal_nociception | 0.71713767 |
| 130 | MP0000955_abnormal_spinal_cord | 0.71311699 |
| 131 | MP0002233_abnormal_nose_morphology | 0.70760280 |
| 132 | MP0009697_abnormal_copulation | 0.68709808 |
| 133 | MP0000751_myopathy | 0.68530387 |
| 134 | MP0005508_abnormal_skeleton_morphology | 0.68385928 |
| 135 | MP0004270_analgesia | 0.66181035 |
| 136 | MP0001986_abnormal_taste_sensitivity | 0.65175461 |
| 137 | MP0001502_abnormal_circadian_rhythm | 0.64030319 |
| 138 | MP0000749_muscle_degeneration | 0.62889252 |
| 139 | MP0000733_abnormal_muscle_development | 0.62840369 |
| 140 | MP0008877_abnormal_DNA_methylation | 0.60862194 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ulnar claw (HP:0001178) | 8.19871258 |
| 2 | Segmental peripheral demyelination/remyelination (HP:0003481) | 6.43688573 |
| 3 | Blue irides (HP:0000635) | 5.48664111 |
| 4 | Hypoplasia of the fovea (HP:0007750) | 5.48297797 |
| 5 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 5.48297797 |
| 6 | Upper limb muscle weakness (HP:0003484) | 5.34598887 |
| 7 | Aplasia/Hypoplasia of the macula (HP:0008059) | 5.01059780 |
| 8 | White forelock (HP:0002211) | 4.80686679 |
| 9 | Impaired proprioception (HP:0010831) | 4.73721514 |
| 10 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 4.65113274 |
| 11 | Abnormality of the fovea (HP:0000493) | 4.58324028 |
| 12 | Termporal pattern (HP:0011008) | 4.38523519 |
| 13 | Insidious onset (HP:0003587) | 4.38523519 |
| 14 | Patchy hypopigmentation of hair (HP:0011365) | 4.35215194 |
| 15 | Pancreatic cysts (HP:0001737) | 4.27485588 |
| 16 | Action tremor (HP:0002345) | 4.18375294 |
| 17 | Peripheral hypomyelination (HP:0007182) | 4.14768960 |
| 18 | Hyperventilation (HP:0002883) | 4.05543215 |
| 19 | Congenital sensorineural hearing impairment (HP:0008527) | 4.02370587 |
| 20 | Abnormal auditory evoked potentials (HP:0006958) | 3.85292365 |
| 21 | Genetic anticipation (HP:0003743) | 3.83022143 |
| 22 | Gaze-evoked nystagmus (HP:0000640) | 3.80355245 |
| 23 | Steppage gait (HP:0003376) | 3.63538969 |
| 24 | Heterochromia iridis (HP:0001100) | 3.37992148 |
| 25 | Chronic hepatic failure (HP:0100626) | 3.34099158 |
| 26 | Progressive cerebellar ataxia (HP:0002073) | 3.32843445 |
| 27 | Ocular albinism (HP:0001107) | 3.30237914 |
| 28 | Medial flaring of the eyebrow (HP:0010747) | 3.24925710 |
| 29 | Attenuation of retinal blood vessels (HP:0007843) | 3.20439796 |
| 30 | Onion bulb formation (HP:0003383) | 3.18834814 |
| 31 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 3.11050799 |
| 32 | Hypoplasia of the iris (HP:0007676) | 3.09137892 |
| 33 | Gait imbalance (HP:0002141) | 3.05718715 |
| 34 | Congenital stationary night blindness (HP:0007642) | 3.04108456 |
| 35 | Iris hypopigmentation (HP:0007730) | 2.98235659 |
| 36 | Abnormality of the renal medulla (HP:0100957) | 2.90251550 |
| 37 | Abnormality of the renal cortex (HP:0011035) | 2.90036491 |
| 38 | Decreased motor nerve conduction velocity (HP:0003431) | 2.89959280 |
| 39 | Congenital primary aphakia (HP:0007707) | 2.89228900 |
| 40 | Focal seizures (HP:0007359) | 2.84712484 |
| 41 | Hypopigmentation of the fundus (HP:0007894) | 2.81908159 |
| 42 | Cystic liver disease (HP:0006706) | 2.76228319 |
| 43 | Genital tract atresia (HP:0001827) | 2.76035510 |
| 44 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 2.74317373 |
| 45 | Cerebellar dysplasia (HP:0007033) | 2.69467325 |
| 46 | Vaginal atresia (HP:0000148) | 2.68545513 |
| 47 | Dialeptic seizures (HP:0011146) | 2.64433364 |
| 48 | Epiphyseal dysplasia (HP:0002656) | 2.64431554 |
| 49 | Hammertoe (HP:0001765) | 2.64035895 |
| 50 | Nephrogenic diabetes insipidus (HP:0009806) | 2.64000806 |
| 51 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.56700940 |
| 52 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.54411750 |
| 53 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.48081738 |
| 54 | Retinal dysplasia (HP:0007973) | 2.46982297 |
| 55 | Facial diplegia (HP:0001349) | 2.46055267 |
| 56 | Abnormal sex determination (HP:0012244) | 2.44732011 |
| 57 | Sex reversal (HP:0012245) | 2.44732011 |
| 58 | Increased CSF protein (HP:0002922) | 2.44531448 |
| 59 | Abolished electroretinogram (ERG) (HP:0000550) | 2.42885972 |
| 60 | Progressive sensorineural hearing impairment (HP:0000408) | 2.40982883 |
| 61 | True hermaphroditism (HP:0010459) | 2.40951814 |
| 62 | Abnormal pupillary function (HP:0007686) | 2.39480312 |
| 63 | Occipital encephalocele (HP:0002085) | 2.39427439 |
| 64 | Broad-based gait (HP:0002136) | 2.39387227 |
| 65 | Hypoplastic ischia (HP:0003175) | 2.38156993 |
| 66 | Intestinal atresia (HP:0011100) | 2.36787789 |
| 67 | Peripheral demyelination (HP:0011096) | 2.36720103 |
| 68 | Abnormality of the ischium (HP:0003174) | 2.36635124 |
| 69 | Hemiparesis (HP:0001269) | 2.29782426 |
| 70 | Absence seizures (HP:0002121) | 2.27170787 |
| 71 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.24744282 |
| 72 | Widely spaced teeth (HP:0000687) | 2.24201487 |
| 73 | Atonic seizures (HP:0010819) | 2.21420105 |
| 74 | Optic nerve hypoplasia (HP:0000609) | 2.20633684 |
| 75 | Protruding tongue (HP:0010808) | 2.20121582 |
| 76 | Papilledema (HP:0001085) | 2.18722152 |
| 77 | Large for gestational age (HP:0001520) | 2.18078493 |
| 78 | Poor coordination (HP:0002370) | 2.17153915 |
| 79 | Inability to walk (HP:0002540) | 2.17026419 |
| 80 | Hypothermia (HP:0002045) | 2.16283018 |
| 81 | Sclerocornea (HP:0000647) | 2.14239703 |
| 82 | Constricted visual fields (HP:0001133) | 2.12311206 |
| 83 | Cupped ear (HP:0000378) | 2.11365396 |
| 84 | Metaphyseal dysplasia (HP:0100255) | 2.09435975 |
| 85 | Abnormality of the vocal cords (HP:0008777) | 2.08701492 |
| 86 | Lissencephaly (HP:0001339) | 2.08510513 |
| 87 | Congenital hepatic fibrosis (HP:0002612) | 2.08351221 |
| 88 | Central scotoma (HP:0000603) | 2.07265275 |
| 89 | Abnormality of midbrain morphology (HP:0002418) | 2.05545713 |
| 90 | Molar tooth sign on MRI (HP:0002419) | 2.05545713 |
| 91 | Generalized hypopigmentation (HP:0007513) | 2.05134342 |
| 92 | Absent speech (HP:0001344) | 2.04427295 |
| 93 | Progressive inability to walk (HP:0002505) | 2.02357304 |
| 94 | Abnormality of the labia minora (HP:0012880) | 2.00757106 |
| 95 | Short foot (HP:0001773) | 1.99796723 |
| 96 | Postural tremor (HP:0002174) | 1.99431198 |
| 97 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.98707933 |
| 98 | Increased density of long bones (HP:0006392) | 1.98636377 |
| 99 | Decreased central vision (HP:0007663) | 1.98610881 |
| 100 | Pancreatic fibrosis (HP:0100732) | 1.97360094 |
| 101 | Preaxial foot polydactyly (HP:0001841) | 1.96677257 |
| 102 | Foot dorsiflexor weakness (HP:0009027) | 1.95574218 |
| 103 | Polydipsia (HP:0001959) | 1.95557369 |
| 104 | Abnormal drinking behavior (HP:0030082) | 1.95557369 |
| 105 | Aplasia cutis congenita (HP:0001057) | 1.95355796 |
| 106 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.95266766 |
| 107 | Absent/shortened dynein arms (HP:0200106) | 1.95266766 |
| 108 | Stomach cancer (HP:0012126) | 1.93841283 |
| 109 | Astigmatism (HP:0000483) | 1.92896872 |
| 110 | Renal cortical cysts (HP:0000803) | 1.92708888 |
| 111 | Furrowed tongue (HP:0000221) | 1.92669022 |
| 112 | Clumsiness (HP:0002312) | 1.92221632 |
| 113 | Anomalous pulmonary venous return (HP:0010772) | 1.91260057 |
| 114 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.90049241 |
| 115 | Midline defect of the nose (HP:0004122) | 1.88469987 |
| 116 | Tubular atrophy (HP:0000092) | 1.88290051 |
| 117 | Type II lissencephaly (HP:0007260) | 1.87218927 |
| 118 | Drooling (HP:0002307) | 1.86421151 |
| 119 | Fair hair (HP:0002286) | 1.85520850 |
| 120 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.84500373 |
| 121 | Nephronophthisis (HP:0000090) | 1.84284258 |
| 122 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.83420975 |
| 123 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.82620602 |
| 124 | Scotoma (HP:0000575) | 1.82123870 |
| 125 | Postaxial hand polydactyly (HP:0001162) | 1.81225714 |
| 126 | Morphological abnormality of the inner ear (HP:0011390) | 1.80592625 |
| 127 | Cutaneous finger syndactyly (HP:0010554) | 1.80381509 |
| 128 | Focal motor seizures (HP:0011153) | 1.79228279 |
| 129 | Abnormality of macular pigmentation (HP:0008002) | 1.78571804 |
| 130 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.78456829 |
| 131 | Hypoplastic labia majora (HP:0000059) | 1.77573124 |
| 132 | Febrile seizures (HP:0002373) | 1.76038206 |
| 133 | Cutaneous syndactyly (HP:0012725) | 1.74779634 |
| 134 | Abnormality of the foot musculature (HP:0001436) | 1.74564130 |
| 135 | Pendular nystagmus (HP:0012043) | 1.74476727 |
| 136 | Synostosis involving the elbow (HP:0003938) | 1.74059874 |
| 137 | Humeroradial synostosis (HP:0003041) | 1.74059874 |
| 138 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.73857146 |
| 139 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.73854331 |
| 140 | Generalized hypopigmentation of hair (HP:0011358) | 1.71518109 |
| 141 | Chorioretinal coloboma (HP:0000567) | 1.70760876 |
| 142 | Preaxial hand polydactyly (HP:0001177) | 1.70477646 |
| 143 | Septo-optic dysplasia (HP:0100842) | 1.67997033 |
| 144 | Small hand (HP:0200055) | 1.67935123 |
| 145 | Neonatal short-limb short stature (HP:0008921) | 1.67911057 |
| 146 | Narrow nasal bridge (HP:0000446) | 1.66702852 |
| 147 | Pulmonary artery stenosis (HP:0004415) | 1.66698962 |
| 148 | Chorioretinal atrophy (HP:0000533) | 1.66064326 |
| 149 | Epileptic encephalopathy (HP:0200134) | 1.66007018 |
| 150 | Abnormality of the pubic bones (HP:0003172) | 1.66000143 |
| 151 | Increased corneal curvature (HP:0100692) | 1.65755723 |
| 152 | Keratoconus (HP:0000563) | 1.65755723 |
| 153 | Retinitis pigmentosa (HP:0000510) | 1.65691406 |
| 154 | Distal sensory impairment (HP:0002936) | 1.64669194 |
| 155 | Postaxial foot polydactyly (HP:0001830) | 1.64518091 |
| 156 | Subacute progressive viral hepatitis (HP:0006572) | 1.63915515 |
| 157 | Hypoplastic pelvis (HP:0008839) | 1.63696036 |
| 158 | Meningocele (HP:0002435) | 1.60055778 |
| 159 | Abnormality of the pulmonary veins (HP:0011718) | 1.59299559 |
| 160 | Freckling (HP:0001480) | 1.59261402 |
| 161 | Sprengel anomaly (HP:0000912) | 1.57500154 |
| 162 | Male pseudohermaphroditism (HP:0000037) | 1.57118034 |
| 163 | Morphological abnormality of the middle ear (HP:0008609) | 1.57114350 |
| 164 | Bell-shaped thorax (HP:0001591) | 1.56612041 |
| 165 | Alacrima (HP:0000522) | 1.54156622 |
| 166 | Decreased lacrimation (HP:0000633) | 1.53401613 |
| 167 | Hypoplastic iliac wings (HP:0002866) | 1.52907290 |
| 168 | Abnormality of incisor morphology (HP:0011063) | 1.52655055 |
| 169 | Aplasia of the phalanges of the hand (HP:0009802) | 1.52541035 |
| 170 | Aplasia involving bones of the extremities (HP:0009825) | 1.52541035 |
| 171 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.52541035 |
| 172 | Progressive hearing impairment (HP:0001730) | 1.50221349 |
| 173 | Conical tooth (HP:0000698) | 1.50026815 |
| 174 | Intellectual disability, moderate (HP:0002342) | 1.49856689 |
| 175 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.49656472 |
| 176 | Anterior segment dysgenesis (HP:0007700) | 1.47675663 |
| 177 | Fetal akinesia sequence (HP:0001989) | 1.47207471 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 8.23070069 |
| 2 | CASK | 7.42793595 |
| 3 | MST1R | 4.82528283 |
| 4 | PRKD3 | 2.98558612 |
| 5 | DDR2 | 2.83981328 |
| 6 | IRAK2 | 2.78141061 |
| 7 | ACVR1B | 2.63782022 |
| 8 | IRAK1 | 2.51455343 |
| 9 | TNIK | 2.44899985 |
| 10 | STK38L | 2.42445419 |
| 11 | NTRK3 | 2.27000266 |
| 12 | TRIM28 | 2.12772693 |
| 13 | MARK3 | 2.11693998 |
| 14 | PDGFRA | 1.96053649 |
| 15 | IRAK4 | 1.95468861 |
| 16 | MAPK13 | 1.90200639 |
| 17 | MAP4K2 | 1.78406707 |
| 18 | PINK1 | 1.78130408 |
| 19 | NEK6 | 1.73828915 |
| 20 | MET | 1.73461260 |
| 21 | LATS1 | 1.65866843 |
| 22 | YES1 | 1.63642064 |
| 23 | ERBB3 | 1.60792576 |
| 24 | RIPK1 | 1.59023056 |
| 25 | FGFR2 | 1.57968396 |
| 26 | MAP2K7 | 1.55320179 |
| 27 | BMX | 1.51781413 |
| 28 | PIK3CG | 1.30278806 |
| 29 | BMPR2 | 1.25620986 |
| 30 | OXSR1 | 1.21574891 |
| 31 | PLK2 | 1.20734592 |
| 32 | ZAK | 1.19260560 |
| 33 | PRPF4B | 1.17965796 |
| 34 | MUSK | 1.17058645 |
| 35 | EIF2AK3 | 1.17009764 |
| 36 | UHMK1 | 1.15150933 |
| 37 | CAMKK2 | 1.14819397 |
| 38 | PNCK | 1.14774031 |
| 39 | MKNK2 | 1.13473303 |
| 40 | STK39 | 1.07247095 |
| 41 | PHKG2 | 1.06359320 |
| 42 | PHKG1 | 1.06359320 |
| 43 | CDK3 | 1.05114798 |
| 44 | MARK1 | 1.02239536 |
| 45 | PRKD2 | 1.01068263 |
| 46 | PTK2B | 0.99875945 |
| 47 | EPHA3 | 0.96877931 |
| 48 | CAMKK1 | 0.95685058 |
| 49 | TAOK3 | 0.95414736 |
| 50 | PAK6 | 0.94763744 |
| 51 | PRKCE | 0.94436590 |
| 52 | MARK2 | 0.93736843 |
| 53 | SIK3 | 0.90086435 |
| 54 | FES | 0.86005432 |
| 55 | DAPK2 | 0.85507099 |
| 56 | PRKCG | 0.83461678 |
| 57 | INSRR | 0.83444388 |
| 58 | PIK3CA | 0.83244675 |
| 59 | STK38 | 0.81112826 |
| 60 | PDK2 | 0.79924616 |
| 61 | MAPK15 | 0.79866146 |
| 62 | WNK4 | 0.79819532 |
| 63 | EPHA4 | 0.79398049 |
| 64 | STK3 | 0.76189368 |
| 65 | MAP3K4 | 0.76118658 |
| 66 | MINK1 | 0.75853065 |
| 67 | PDGFRB | 0.74804836 |
| 68 | SGK2 | 0.74462415 |
| 69 | CSNK1G1 | 0.72553976 |
| 70 | MAP3K14 | 0.70486339 |
| 71 | WNK1 | 0.69064832 |
| 72 | PAK3 | 0.63833783 |
| 73 | NUAK1 | 0.63582717 |
| 74 | LMTK2 | 0.63568785 |
| 75 | AKT3 | 0.61604619 |
| 76 | TGFBR1 | 0.60519471 |
| 77 | MAP3K12 | 0.60250097 |
| 78 | RET | 0.60051889 |
| 79 | PKN1 | 0.59135094 |
| 80 | TXK | 0.56881313 |
| 81 | MAP3K6 | 0.55922422 |
| 82 | CAMK1 | 0.55190143 |
| 83 | GRK1 | 0.53244326 |
| 84 | DYRK2 | 0.53108093 |
| 85 | WNK3 | 0.52744038 |
| 86 | CDK5 | 0.52406746 |
| 87 | TNK2 | 0.51998044 |
| 88 | PRKCH | 0.51838445 |
| 89 | SGK494 | 0.51164142 |
| 90 | SGK223 | 0.51164142 |
| 91 | CSNK1A1L | 0.49462602 |
| 92 | DYRK1A | 0.47726336 |
| 93 | MKNK1 | 0.46396002 |
| 94 | EIF2AK2 | 0.46200718 |
| 95 | BMPR1B | 0.46191064 |
| 96 | MYLK | 0.45803223 |
| 97 | ERBB4 | 0.45641300 |
| 98 | TRPM7 | 0.45384436 |
| 99 | ROCK1 | 0.44773577 |
| 100 | CAMK2A | 0.43398289 |
| 101 | SIK2 | 0.42810805 |
| 102 | NLK | 0.42670439 |
| 103 | PRKACA | 0.41926713 |
| 104 | NTRK2 | 0.41712765 |
| 105 | MELK | 0.41604851 |
| 106 | PRKCZ | 0.41121226 |
| 107 | OBSCN | 0.40936634 |
| 108 | RIPK4 | 0.40615997 |
| 109 | SRPK1 | 0.39624221 |
| 110 | MAP2K4 | 0.39600217 |
| 111 | PRKG1 | 0.39524027 |
| 112 | FGFR1 | 0.38848666 |
| 113 | BCR | 0.38550455 |
| 114 | ADRBK1 | 0.38291185 |
| 115 | STK11 | 0.36938135 |
| 116 | ERBB2 | 0.36427878 |
| 117 | KSR1 | 0.36157721 |
| 118 | MST4 | 0.36119342 |
| 119 | CLK1 | 0.34845623 |
| 120 | FGR | 0.34749764 |
| 121 | CSNK1G3 | 0.34146452 |
| 122 | CSNK1D | 0.34104730 |
| 123 | HIPK2 | 0.34047866 |
| 124 | CSNK1A1 | 0.33478874 |
| 125 | MAP3K1 | 0.32262853 |
| 126 | GRK7 | 0.32220770 |
| 127 | PBK | 0.31759141 |
| 128 | PRKACB | 0.31636597 |
| 129 | CAMK2B | 0.31025375 |
| 130 | PRKAA1 | 0.30849110 |
| 131 | CHUK | 0.30371503 |
| 132 | MAP2K6 | 0.30186536 |
| 133 | CAMK1G | 0.29827235 |
| 134 | ADRBK2 | 0.29759531 |
| 135 | LIMK1 | 0.29745763 |
| 136 | PRKCQ | 0.29607655 |
| 137 | CDK7 | 0.29494974 |
| 138 | CSNK1G2 | 0.29055616 |
| 139 | MAP3K7 | 0.28967445 |
| 140 | FER | 0.28767532 |
| 141 | MAPKAPK5 | 0.28681113 |
| 142 | TEC | 0.28494594 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.53369005 |
| 2 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.52367871 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.46173647 |
| 4 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.43547335 |
| 5 | Axon guidance_Homo sapiens_hsa04360 | 1.92986658 |
| 6 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.85829912 |
| 7 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.82471695 |
| 8 | ABC transporters_Homo sapiens_hsa02010 | 1.82414728 |
| 9 | Nicotine addiction_Homo sapiens_hsa05033 | 1.81333710 |
| 10 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.76229572 |
| 11 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.74503401 |
| 12 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.70706967 |
| 13 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.68538164 |
| 14 | Melanoma_Homo sapiens_hsa05218 | 1.67986117 |
| 15 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.67529616 |
| 16 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.66439924 |
| 17 | Taste transduction_Homo sapiens_hsa04742 | 1.66396926 |
| 18 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.65751238 |
| 19 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.64800439 |
| 20 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.57864500 |
| 21 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.57175806 |
| 22 | Melanogenesis_Homo sapiens_hsa04916 | 1.54430604 |
| 23 | Long-term depression_Homo sapiens_hsa04730 | 1.47962652 |
| 24 | Olfactory transduction_Homo sapiens_hsa04740 | 1.45045661 |
| 25 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.44890983 |
| 26 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.42261609 |
| 27 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.41964235 |
| 28 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.41814651 |
| 29 | Circadian entrainment_Homo sapiens_hsa04713 | 1.39857852 |
| 30 | Morphine addiction_Homo sapiens_hsa05032 | 1.39285139 |
| 31 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.38515431 |
| 32 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.36158880 |
| 33 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.34220763 |
| 34 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.33396249 |
| 35 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.29749010 |
| 36 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.25090560 |
| 37 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.23478703 |
| 38 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.19626425 |
| 39 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.18061677 |
| 40 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.16011061 |
| 41 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.14927600 |
| 42 | Cocaine addiction_Homo sapiens_hsa05030 | 1.13325593 |
| 43 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.12278280 |
| 44 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.11966895 |
| 45 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.06518861 |
| 46 | Gap junction_Homo sapiens_hsa04540 | 1.06103747 |
| 47 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.06103263 |
| 48 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.06027472 |
| 49 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.05300917 |
| 50 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.04235946 |
| 51 | Salivary secretion_Homo sapiens_hsa04970 | 1.03529686 |
| 52 | Basal transcription factors_Homo sapiens_hsa03022 | 1.02758399 |
| 53 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.01837075 |
| 54 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.01784712 |
| 55 | Protein export_Homo sapiens_hsa03060 | 1.00701924 |
| 56 | Insulin secretion_Homo sapiens_hsa04911 | 0.99874864 |
| 57 | Homologous recombination_Homo sapiens_hsa03440 | 0.99195898 |
| 58 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.97636458 |
| 59 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.97269720 |
| 60 | * Focal adhesion_Homo sapiens_hsa04510 | 0.96819134 |
| 61 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.96350294 |
| 62 | Endometrial cancer_Homo sapiens_hsa05213 | 0.95081660 |
| 63 | GABAergic synapse_Homo sapiens_hsa04727 | 0.94799844 |
| 64 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.94714775 |
| 65 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.94490389 |
| 66 | Retinol metabolism_Homo sapiens_hsa00830 | 0.94272504 |
| 67 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.93185083 |
| 68 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.92578591 |
| 69 | * ErbB signaling pathway_Homo sapiens_hsa04012 | 0.92198209 |
| 70 | Lysine degradation_Homo sapiens_hsa00310 | 0.91272971 |
| 71 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.90632913 |
| 72 | * Glioma_Homo sapiens_hsa05214 | 0.89806067 |
| 73 | Renin secretion_Homo sapiens_hsa04924 | 0.89747299 |
| 74 | Long-term potentiation_Homo sapiens_hsa04720 | 0.89538496 |
| 75 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.89118249 |
| 76 | Histidine metabolism_Homo sapiens_hsa00340 | 0.87847649 |
| 77 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.86796228 |
| 78 | Phototransduction_Homo sapiens_hsa04744 | 0.83577399 |
| 79 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.82969500 |
| 80 | Phagosome_Homo sapiens_hsa04145 | 0.82706275 |
| 81 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.82482603 |
| 82 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.81494382 |
| 83 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.81492136 |
| 84 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.81056315 |
| 85 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.79744057 |
| 86 | * Alcoholism_Homo sapiens_hsa05034 | 0.79704627 |
| 87 | Salmonella infection_Homo sapiens_hsa05132 | 0.79341165 |
| 88 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.79101851 |
| 89 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.78925825 |
| 90 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.78611126 |
| 91 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.78424981 |
| 92 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.78164330 |
| 93 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.74905861 |
| 94 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.74312994 |
| 95 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.73856603 |
| 96 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.73748206 |
| 97 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.73731793 |
| 98 | * Ras signaling pathway_Homo sapiens_hsa04014 | 0.73721086 |
| 99 | Allograft rejection_Homo sapiens_hsa05330 | 0.73442450 |
| 100 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.72825922 |
| 101 | Malaria_Homo sapiens_hsa05144 | 0.72531917 |
| 102 | Prostate cancer_Homo sapiens_hsa05215 | 0.71690849 |
| 103 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.71321751 |
| 104 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.70458575 |
| 105 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.69257294 |
| 106 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.68237084 |
| 107 | * Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.68220028 |
| 108 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.66902961 |
| 109 | Viral myocarditis_Homo sapiens_hsa05416 | 0.66208599 |
| 110 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.66164062 |
| 111 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.65790092 |
| 112 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.64796974 |
| 113 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.63473871 |
| 114 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.63281983 |
| 115 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.62767183 |
| 116 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.62404828 |
| 117 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.62267869 |
| 118 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.61816014 |
| 119 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.61386259 |
| 120 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.60447606 |
| 121 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.60358663 |
| 122 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.59615984 |
| 123 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.58951823 |
| 124 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.58902648 |
| 125 | Peroxisome_Homo sapiens_hsa04146 | 0.58532417 |
| 126 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.58486186 |
| 127 | Tight junction_Homo sapiens_hsa04530 | 0.58153493 |
| 128 | Circadian rhythm_Homo sapiens_hsa04710 | 0.57734370 |
| 129 | * MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.57652741 |
| 130 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.57485169 |
| 131 | Pathways in cancer_Homo sapiens_hsa05200 | 0.56283180 |
| 132 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.56256265 |
| 133 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.55647060 |
| 134 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.55107511 |
| 135 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.53585307 |
| 136 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.53392384 |
| 137 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.52641671 |
| 138 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51839910 |
| 139 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.50645680 |
| 140 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.50240642 |
| 141 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.47196241 |
| 142 | Bile secretion_Homo sapiens_hsa04976 | 0.39321653 |
| 143 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.38842602 |
| 144 | RNA polymerase_Homo sapiens_hsa03020 | 0.38261958 |
| 145 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.34242588 |
| 146 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.33257534 |
| 147 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.31922821 |
| 148 | Mineral absorption_Homo sapiens_hsa04978 | 0.30617774 |
| 149 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.29073358 |

